ECO-based nanoparticles can also be chemically modified with targeting ligands; the addition of a retinylamide or its analogue ACU4429 produced increased RPE expression in Rpe65−/− LCA model mice and Abca4−/− mice, respectively [37,38]. This evidence concerns the gene RPE65 and Leber congenital amaurosis.